June 18 - A federal judge in Texas has upheld the U.S.
Food and Drug Administration's decision to remove Novo Nordisk's
blockbuster drugs Ozempic and Wegovy from the drug shortage
list, rejecting a challenge brought by compounding pharmacies
who sought to continue making copies of the drugs.
(Reporting by Diana Novak Jones in Chicago)